Inovio Wins $71 Million Department of Defense Contract for Its COVID-19 Vaccine Delivery Devices
The biotech also said it will announce results from phase 1 testing of its COVID-19 vaccine candidate, INO-4800, by the end of June.
Full Article
Inovio Wins $71 Million Department of Defense Contract for Its COVID-19 Vaccine Delivery Devices
Motley Fool
0 shares
1 views
You might like
Related news coverage
3P’s: Post Pandemic Preparation Advisory – Analysis
Eurasia Review
A pandemic, a microbial mediated disaster, is very difficult to tackle. This may had happened because of lack of awareness of..
-
INO Hits New High, APYX Expands Footprint, TBIO/SNY To Begin COVID-19 Vaccine Trial In Q4
RTTNews
-
Stock Alert: Inovio Gains 16% On Getting US Defense Dept. Contract
RTTNews
-
Inovio gets $71M grant to scale up delivery device for potential Covid-19 vaccine
bizjournals
-
Stock Alert: Inovio Pharma Shares Up 12% In Pre-Market On $71 Mln Contract From DoD
RTTNews